India Animal Health Market Size, Share, Trends, Top Companies, Industry Growth And Outlook 2025-2033

(MENAFN- IMARC Group) The India animal health market was valued at INR 86.2 Billion in 2024 and is expected to reach INR 169.6 Billion by 2033 , growing at a CAGR of 7.41% from 2025 to 2033 . The market is experiencing strong growth driven by increasing livestock population, rising pet ownership, growing demand for animal-derived food products, and heightened awareness regarding animal welfare and disease prevention. Key Highlights

• Market size (2024): INR 86.2 Billion
• Forecast (2033): INR 169.6 Billion
• CAGR (2025–2033): 7.41%
• Livestock and companion animal care gaining traction amid increased veterinary awareness
• Expansion of animal health infrastructure and public-private vaccination initiatives
• Key companies operating in the India animal health market include Bayer CropScience Limited, Boehringer Ingelheim Animal Health, Cargill India Pvt. Ltd., Merck, Ceva Sante Animale, Elanco India Private Limited, Virbac Animal Health India Pvt Ltd.

Request Free Sample Report: https://www.imarcgroup.com/india-animal-health-market/requestsample

How Is AI Transforming the Animal Health Market in India?

• Real-time animal monitoring through wearables and smart sensors
• Tele-veterinary services improving accessibility in rural areas
• AI-driven diagnostics and precision medicine for early disease detection
• Blockchain in livestock traceability and vaccine supply chains

Key Market Trends and Drivers

• Rising Livestock Population: India is one of the largest producers of dairy, poultry, and meat, leading to growing demand for preventive healthcare
• Growing Pet Ownership: Urbanization and rising disposable incomes are increasing pet adoption, especially in Tier 1 and Tier 2 cities
• Government Vaccination Programs: National disease control programs targeting FMD and brucellosis are improving herd immunity
• Emerging Zoonotic Threats: Increased vigilance and preparedness for zoonotic diseases are boosting veterinary diagnostics and pharmaceuticals
• Private Sector Investments: Expansion of animal hospitals, diagnostic labs, and R&D initiatives supporting innovation in animal healthcare

Market Segmentation

Breakup by Animal Type:

• Commercial
• Companion

Breakup by Product Type:

• Anti-Bacterial/Antibiotic
• Anti-Chronic Respiratory
• Anticoccidials
• Dewormers/Anthelmintics
• Disinfectants
• Enzymes
• Fly-Binder/Control
• Growth Promoters
• Gut Health (also includes probiotics, prebiotics)
• Liver Tonics
• Nutritional Supplements
• Toxin Binders/Immunomodulators/Mold inhibitors
• Vaccines
• Vitamins/ Minerals/ Amino Acids
• Diagnostics

Breakup by Distribution Channel:

• Veterinary Hospitals
• Veterinary Clinics
• Pharmacies and Drug Stores
• Others

Breakup by Region:

• Uttar Pradesh
• Rajasthan
• Madhya Pradesh
• Bihar
• Andhra Pradesh
• Gujarat
• Others

Latest Developments in the Industry

• In April 2025, a major Indian pharmaceutical firm launched a new range of multi-spectrum vaccines for cattle and poultry, aimed at boosting disease resistance and productivity.
• In January 2025 , a startup based in Bengaluru introduced India's first AI-powered livestock health monitoring wearable, gaining strong interest from dairy cooperatives.
• The Indian government announced a National Animal Disease Reporting System upgrade in 2025 , with enhanced surveillance and real-time analytics for managing veterinary outbreaks more effectively.

MENAFN07082025004122016232ID1109897780